EVER Pharma
Ahmed Gad is a seasoned professional in the pharmaceutical industry, currently serving as Market Access Manager at EVER Pharma since April 2021. Prior to this role, Ahmed held various positions at Sandoz from May 2015 to April 2021, including KAM Assignee, Senior Biosimilars Specialist, and Oncology Product Specialist, where responsibilities included launching and promoting the Sandoz biosimilars portfolio and promoting chemotherapy and hormonal therapy products. Earlier experience includes working as an Oncology Product Specialist at Hospira from November 2012 to May 2015. Ahmed holds a Bachelor of Pharmacy (B.Pharm.) from Misr University for Science and Technology, completed in 2011.
This person is not in any offices
EVER Pharma
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics. From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety. Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.